Lenzing Delays Heiligenkreuz Closure to Early 2027 as Investors Weigh Post-Rights-Issue Prospects
Published on 10/28/2026 at 14:31 | Editorial boerse-global.de
Lenzing has pushed back the planned shutdown of its Heiligenkreuz plant, confirming to the APA news agency on 22 October a report that the site will now close in the first quarter of 2027 rather than at the end of 2026. The company attributed the revised timetable to the transfer of production to other locations.
The announcement lands barely a week after the Austrian fibre maker wrapped up a capital increase that raised roughly EUR 301.2 million in gross proceeds, issuing 34,756,362 new shares at a 99% take-up rate. Lenzing booked the shares shortly before the disclosure, lifting its share capital to EUR 76,204,702.90, according to a voting-rights notification published the previous day. The total number of voting rights now stands at 73,374,542.
Ownership Picture Sharpens
Goldman Sachs reported a voting-rights position in Lenzing totalling 5.86%, split between 4.88% held in shares and 0.98% in financial instruments. The disclosure documents a stake, not an improvement in the underlying business — a distinction that matters for anyone reading it as an endorsement of the company's strategy.
The syndicate of B&C and Suzano holds a combined 52.25% following the capital increase, with Suzano Holding S.A. holding an additional roughly 0.80% outside the grouping. Syndicate members subscribed to 18,159,291 of the new shares between them, and Georg Kasperkovitz also reported a purchase made under the subscription rights offering.
That clarifies how voting power is distributed, though it says nothing about the economic impact of the measures the fresh money is meant to fund. Ownership structure, financing and operating performance are separate layers of the investment case — they belong together, but none substitutes for another.
Should investors sell immediately? Or is it worth buying Lenzing?
Financing Is a Starting Point, Not a Verdict
The proceeds are earmarked for Lenzing's "Grow Nonwovens, Reset Textiles" strategy and for shoring up the balance sheet. The 99% subscription rate points to broad participation in the cash call — a positive financing outcome, and no more than that. Subscribing to new shares is not an earnings statement, nor proof that the turnaround is delivering.
The use of proceeds therefore deserves closer attention than the flow of stake disclosures. What will matter for valuation is the economic progress that follows. The yardstick should be the development of the business itself, not the number of further regulatory filings.
None of this diminishes the capital measure. A stronger capital base and funding for the strategy are meaningful steps. The error would be to mistake those preconditions for the success they are meant to enable. Fresh capital opens doors; its economic value has yet to be demonstrated.
November 5 Looms as the Real Test
Lenzing's next confirmed reporting date is 5 November 2026, when the company will present third-quarter results. That appointment carries more weight than another notification about voting rights, because it shifts the focus from ownership positions to actual trading figures.
Demanding full proof of the realignment from a single quarterly report would be excessive. Investors can, however, scrutinise what management says about business performance and the pace of strategy execution — and that is where the assessment should begin.
The stock's recent moves underline how sentiment is swinging on news flow rather than fundamentals. Shares fell 5.1% to EUR 9.93 in the session before the delay was confirmed, with Reuters reporting that the early-October announcement of the capital increase had weighed on the paper. A 4.3% gain on the day of the stake disclosures offered a partial rebound, though that filing does not by itself explain the advance.
Weighing it all up, the picture stays cautious: the financing is tangible progress, operational success is not yet proven, and the Heiligenkreuz timeline now stretches further into 2027 while production migrates elsewhere. More convincing grounds for confidence would be hard evidence of progress in the business — not merely new names or shifted percentages in voting-rights filings.
Ad
Lenzing Stock: New Analysis - 28 October
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
